‌

US Patent 11446369 Compositions and methods comprising KLK3 or FOLH1 antigen

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Vafa Shahabi0

Yvonne Paterson0

John Rothman0

Date of Patent

September 20, 2022

0

Patent Application Number

166723620

Date Filed

November 1, 2019

0

Patent Citations

US Patent 10166276 Compositions and methods for treatment of non-hodgkins lymphoma

US Patent 10143734 Biomarker directed multi-target immunotherapy

US Patent 10010593 Recombinant

US Patent 10016617 Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers

US Patent 10064898 Listeria-based adjuvants

0

US Patent 10058599 Suppressor cell function inhibition following

US Patent 10900044 Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof

0

US Patent 10258679 Recombinant

...

Patent Citations Received

US Patent 11702664 Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof

0

Patent Primary Examiner

0

CPC Code

0

The present invention provides KLK3 peptides, FOLH1 peptides, recombinant polypeptides comprising same, recombinant nucleotide molecules encoding same, recombinant

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11446369 Compositions and methods comprising KLK3 or FOLH1 antigen

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.